(Anastassiya Bezhekeneva/Getty Images) A large umbrella review has found no strong evidence to date that medicinal cannabis ...

By Sriparna Roy March 16 (Reuters) - Cannabis-based medicines have shown little evidence of effectiveness for treating most ...

Leading Australian psychiatrists say the findings should serve as a wake-up call for the government to better regulate the $1 ...

Increasing numbers of Australians are using medicinal cannabis for anxiety, depression, insomnia, substance disorders and ...

There’s ‘no evidence’ marijuana works to treat most mental health disorders, largest review of its kind finds - More than 52 ...

A new analysis represents the largest effort yet to systematically parse all the data from high-quality clinical trials on cannabis and mental health. The evidence is lacking.

NEW YORK, Sept. 18, 2024 (GLOBE NEWSWIRE) -- Tilray Medical, a division of Tilray Brands, Inc. ("Tilray Brands") (NASDAQ: TLRY and TSX: TLRY) and a global leader in medical cannabis, empowering the ...

EDMONTON, AB, June 5, 2025 /PRNewswire/ - Aurora Cannabis Inc. (NASDAQ: ACB) (TSX: ACB), the Canadian-based leading global medical cannabis company, has expanded their popular IndiMed brand with the ...

Many people say they use cannabis for their mental health, but researchers find there is little to no evidence that cannabis can be beneficial for any psychiatric condition.

In just a few short years, Australia’s cannabis industry has evolved from a policy debate to a rapidly expanding medical industry. Now valued at over $230 million AUD as of 2023, the country’s legal ...

Years in the making, the Canadian LP is finding markets closer to the pharmaceutical industry in highly regulated medical cannabis markets.

Chief Financial Officer Simona King outlined the company’s recent strategic pivot toward medical cannabis and international ...